Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Heliyon|November 29, 2021
Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodiesMagdalena M Żak, Aryeh Stock, Daniel Stadlbauer, et al.Vaccines|January 14, 2021
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret ModelWen-Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer, et al.Journal of Virology|November 2, 2023
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A virusesWillemijn Frederique Rijnink, Daniel Stadlbauer, Eduard Puente-Massaguer, et al.The Journal of Infectious Diseases|May 9, 2024
Humoral Correlates of Protection Against Influenza A/H3N2 Virus InfectionGregory Hoy, Daniel Stadlbauer, Angel Balmaseda, et al.Vaccine|May 12, 2020
Antibody responses to influenza A(H1N1)pdm infectionSteph Wraith, Raffael Nachbagauer, Angel Balmaseda, et al.NPJ Vaccines|December 10, 2022
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccinationTeresa Aydillo, Ana S Gonzalez-Reiche, Daniel Stadlbauer, et al.Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Anti-Neuraminidase Antibodies Reduce the Susceptibility to and Infectivity of Influenza A/H3N2 VirusGregory Hoy, Thomas Cortier, Hannah E Maier, et al.Nature Communications|December 11, 2025
Anti-neuraminidase and anti-HA stalk antibodies reduce the susceptibility to and infectivity of influenza A/H3N2 virusGregory Hoy, Thomas Cortier, Hannah E Maier, et al.Nature Communications|June 19, 2023
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysisIvan T Lee, Raffael Nachbagauer, David Ensz, et al.Nature Medicine|June 5, 2019
Novel correlates of protection against pandemic H1N1 influenza A virus infectionSophia Ng, Raffael Nachbagauer, Angel Balmaseda, et al.Pageof 6